Buerger's Disease: A Distinct Clinical Entity
- 1 September 1980
- journal article
- research article
- Published by SAGE Publications in Vascular Surgery
- Vol. 14 (5) , 346-351
- https://doi.org/10.1177/153857448001400508
Abstract
Retention of thromboangiitis obliter ans as a distinct clinical entity contin ues to have considerable value in the logical planning of treatment and long- term care of these patients. Throm boangiitis obliterans has a unique prog nosis and associated factors, especially tobacco consumption, are extremely important. It is hoped that further re search may delineate the pathogenesis of Buerger's disease so that patients can be properly educated and reas sured.This publication has 11 references indexed in Scilit:
- Intermittent claudication in the foot and buerger's diseaseBritish Journal of Surgery, 1978
- Association of HLA-A9 and HLA-B5 with Buerger's disease.BMJ, 1976
- Vascular reconstruction in Buerger's diseaseBritish Journal of Surgery, 1976
- Some Hematologic Differences Between Thromboangiitis Obliterans and AtherosclerosisAngiology, 1968
- Thromboangiitis Obliterans and Arteriosclerosis ObliteransAnnals of Internal Medicine, 1963
- Buerger's Disease: A Distinct Clinical and Pathologic EntityPublished by American Medical Association (AMA) ,1962
- EditorialCirculation, 1962
- A Critical Evaluation of Thromboangiitis ObliteransNew England Journal of Medicine, 1960
- A Reconsideration of the Pathogenesis of Buerger's DiseaseAmerican Journal of Clinical Pathology, 1958
- THROMBO-ANGIITIS OBLITERANSThe Lancet Healthy Longevity, 1908